Clinical Trials Sponsored by Barbara Ensoli, MD, PhD

Total 10 results

Barbara Ensoli, MD, PhD

Suspended

Observational Study for the Evaluation of the Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV Reservoir (ISS OBS T-005)

HIV/AIDS

Italy
Barbara Ensoli, MD, PhD

Completed

Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma

Kaposi's Sarcoma

Italy
Barbara Ensoli, MD, PhD

Completed

Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002 (ISST-002 EF-UP)

HIV Infection

Italy
Barbara Ensoli, MD

Completed

Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects (ISS OBS T-002)

HIV Infection

Italy
Barbara Ensoli, MD

Completed

Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine (ISS T-002)

HIV Infections

Italy
Barbara Ensoli, MD

Completed

Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects (ISS OBS T-003)

HIV Infections

Italy
Barbara Ensoli, MD
Novartis Vaccines

Terminated

A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)

HIV Infection

Italy
Barbara Ensoli, MD, PhD
Italian Ministry of Foreign Affairs - General Direction for Cooperation and...

Completed

A Roll-over Observational Study for the Extended Follow-up of the Volunteers of the ISS T-003 Trial (ISST-003EF-UP)

HIV Infections

South Africa
Barbara Ensoli, MD
Italian Ministry of Foreign Affairs - General Direction for Cooperation and...

Completed

A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infected, Anti-Tat Negative, ARV-Treated Adult Volunteers (ISS T-003)

HIV Infections

South Africa
Barbara Ensoli, MD
Italian Ministry of Foreign Affairs - Dir. Gen. for Cooperation and Development

Completed

Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients (ISS OBS T-004)

HIV Infection

South Africa

3

Subscribe